Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Trial in Progress: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 2 Study of AK117/Placebo in Combination with Azacitidine in Patients with Newly Diagnosed Higher-Risk Myelodysplastic Syndromes (AK117-205)

Amer M. Zeidan, Hongyan Tong, Zhijian Xiao, Praneeth Baratam, Ramzi Abboud, Christopher B. Benton, Joshua F Zeidner, Uma Borate, Wanxing Chai-Ho, Yonglin Lu, Jie Yang, Mingxiu Hu, Baiyong Li, Michelle Xia, David Sallman

Blood (2024) 144 (Supplement 1): 6705.

https://doi.org/10.1182/blood-2024-200541

Published: 2024

Journal Articles

Short-Term Efficacy and Safety of Blinatumomab in Early Postinduction Intensification Therapy for Pediatric B-Cell Acute Lymphoblastic Leukemia

Yanming Li, Peijing Qi, Ying Wu, Jiaole Yu, Yuanyuan Zhang, Huiqing Liu, Bei Hou, Jie Yang, Huyong Zheng, Tianyou Wang, Ruidong Zhang

Blood (2023) 142 (Supplement 1): 5901.

https://doi.org/10.1182/blood-2023-188669

Published: 2023

Journal Articles

Clinical Study on Part Factors Affecting the Effect of Platelet Transfusion during Hematopoietic Stem Cell Transplantation

Jie Yang, Xiuwen Li, Bao-An Chen, MD PhD

Blood (2019) 134 (Supplement_1): 4987.

https://doi.org/10.1182/blood-2019-122989

Published: 2019

Journal Articles

Iron Catalyzed Hydrogen Sulfide and Its Prevalence during Oxidative Events in Sickle Cell Disease

Jie Yang, PhD, Nazmin Bithi, B.Sc, Christopher Link, B.Sc, Yogenthiran Saunthararajah, MD, Christopher Hine, PhD

Blood (2019) 134 (Supplement_1): 3534.

https://doi.org/10.1182/blood-2019-122985

Published: 2019

Journal Articles

Novel Fusion Genes Involving Hnrnpc and Rarg in Acute Myeloid Leukemia Mimicking Acute Promyelocytic Leukemia

Zhan Su, MD, Xin Liu, MD PhD, Yan Xu, MD, Weiyu Hu, MD, Chunting Zhao, MD, Hongguo Zhao, MD, Xianqi Feng, MD, Shuchao Zhang, Jie Yang, Xue Shi, Lugui Qiu, MD PhD, Jun Peng, MD PhD

Blood (2018) 132 (Supplement 1): 5274.

https://doi.org/10.1182/blood-2018-99-111433

Published: 2018

Journal Articles

Negative Minimal Residual Disease Associated with Extended Response to Moxetumomab Pasudotox in Patients with Relapsed/Refractory Hairy Cell Leukemia: Long-Term Follow-up of Bone Marrow Immunohistochemistry Analyses from a Phase 1 Study

Robert Kreitman, MD, Martin S. Tallman, MD, Tadeusz Robak, MD PhD, Steven Coutre, MD, Shannon Marshall, PhD, Jie Yang, PhD, Ira Pastan, MD, Nai Shun (Nancy) Yao, MD

Blood (2017) 130 (Supplement 1): 2765.

https://doi.org/10.1182/blood.V130.Suppl_1.2765.2765

Published: 2017

Journal Articles

Co-Loaded Reversal Agent and Chemotherapeutic Nanoerythrosomes to Overcome Cancer Multidrug Resistance

Shuang Ding, MSc, Baoan Chen, MDPhD, Haijun ZHang, MDPhD, Jie Yang

Blood (2017) 130 (Supplement 1): 4995.

https://doi.org/10.1182/blood.V130.Suppl_1.4995.4995

Published: 2017

Journal Articles

Phase 1 study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemia

Alan S. Wayne, Nirali N. Shah, Deepa Bhojwani, Lewis B. Silverman, James A. Whitlock, Maryalice Stetler-Stevenson, Weili Sun, Meina Liang, Jie Yang, Robert J. Kreitman, Mark C. Lanasa, Ira Pastan

Blood (2017) 130 (14): 1620–1627.

https://doi.org/10.1182/blood-2017-02-749101

Published: 2017

Includes: Supplemental data

Journal Articles

Biomarker Predictive Ibrutinib Response Using Profiled ABC-DLBCL Patient Derived Xenografts

Ran Wu, PhD, Sheng Guo, Jie Cai, PhD, Xuesong Huang, Jie Yang, Jean-Pierre Wery, Henry Qi-xiang Li, PhD

Blood (2015) 126 (23): 2759.

https://doi.org/10.1182/blood.V126.23.2759.2759

Published: 2015

Journal Articles

Higher bone marrow LGALS3 expression is an independent unfavorable prognostic factor for overall survival in patients with acute myeloid leukemia

Chieh-Lung Cheng, Hsin-An Hou, Ming-Cheng Lee, Chieh-Yu Liu, Jie-Yang Jhuang, Yan-Jun Lai, Chung-Wu Lin, Huan-Yuan Chen, Fu-Tong Liu, Wen-Chien Chou, Chien-Yuan Chen, Jih-Luh Tang, Ming Yao, Shang-Yi Huang, Bor-Sheng Ko, Shang-Ju Wu, Woei Tsay, Hwei-Fang Tien

Blood (2013) 121 (16): 3172–3180.

https://doi.org/10.1182/blood-2012-07-443762

Published: 2013

Includes: Supplemental data

Journal Articles

Characterization of the Two Populations of NK-Like CD56 + T Cells and KIR + T Cells in Human

Wing Keung Chan, PhD, Piya Rujkijyanont, MD, Geoffrey A. Neale, PhD, Jie Yang, PhD, Rafijul Bari, PhD, Neha Das Gupta, MS, Martha Holladay, BSc, Barbara Rooney, MS, Susanne Wendt, MD, Wing Leung, MD, PhD

Blood (2012) 120 (21): 3292.

https://doi.org/10.1182/blood.V120.21.3292.3292

Published: 2012

Journal Articles

Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia

Blood (2012) 120 (2): 468–472.

https://doi.org/10.1182/blood-2012-02-409813

Published: 2012

Journal Articles

Longitudinal Analysis of Body Mass and Composition in Survivors of Pediatric Hematological Malignancies After Allogeneic Hematopoietic Stem Cell Transplantation

Hiroto Inaba, MD, PhD, Jie Yang, PhD, Sue Kaste, DO, Christine Hartford, MD, Megan S Motosue, MD, Ashok Srinivasan, MD, Brandon M. Triplett, MD, David R Shook, MD, Ching-Hon Pui, MD, Wing Leung, MD, PhD

Blood (2011) 118 (21): 1991.

https://doi.org/10.1182/blood.V118.21.1991.1991

Published: 2011

Journal Articles

High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia

Wing Leung, Dario Campana, Jie Yang, Deqing Pei, Elaine Coustan-Smith, Kwan Gan, Jeffrey E. Rubnitz, John T. Sandlund, Raul C. Ribeiro, Ashok Srinivasan, Christine Hartford, Brandon M. Triplett, Mari Dallas, Asha Pillai, Rupert Handgretinger, Joseph H. Laver, Ching-Hon Pui

Blood (2011) 118 (2): 223–230.

https://doi.org/10.1182/blood-2011-01-333070

Published: 2011

Includes: Supplemental data

Journal Articles

Parainfluenza Virus Infections In Children with Cancer

Ashok Srinivasan, MD, Chong Wang, MS, Jie Yang, PhD, Hiroto Inaba, MD, PhD, Wing H Leung, MD.PhD, Randall T Hayden, MD

Blood (2010) 116 (21): 3909.

https://doi.org/10.1182/blood.V116.21.3909.3909

Published: 2010

Journal Articles

Longitudinal Analysis of Antibody Response to Immunization in Pediatric Survivors After Allogeneic Hematopoietic Stem Cell Transplantation.

Hiroto Inaba, MD, PhD, Meredith Posner, Christine Hartford, MD, Jie Yang, PhD, Deqing Pei, MS, Randall Hayden, MD, Ashok Srinivasan, MD, Brandon Triplett, MD, Ching-Hon Pui, MD, Wing Leung, MD, PhD

Blood (2009) 114 (22): 795.

https://doi.org/10.1182/blood.V114.22.795.795

Published: 2009

Journal Articles

By Maintaining Cells in an Inactive CD34 − State RNA-Binding Protein Pum2 Promotes Proliferation and Inhibits Differentiation of Multipotent Hematopoietic Cells.

Jie Yang, MD, Kyle Di Vito, M.Sc., Ronald G. Nachtman, Ph.D., Roland Jurecic, Ph.D.

Blood (2006) 108 (11): 1354.

https://doi.org/10.1182/blood.V108.11.1354.1354

Published: 2006

Journal Articles

The Role of Truncated c-kit Receptor (tr-kit) in Maintenance and Differentiation of Hematopoietic Stem Cells and Multipotent Hematopoietic Progenitors.

Jie Yang, MD, Candice I. Saltiel, Ronald G. Nachtman, PhD, Xin Jing, PhD, Roland Jurecic, PhD

Blood (2005) 106 (11): 4193.

https://doi.org/10.1182/blood.V106.11.4193.4193

Published: 2005

Journal Articles

Expression of Cadherins in Bone Marrow Stromal Cells Affects Capacity Supporting Expansion of CD34+ Cord Blood Cells.

Jin-Hwang Liu, MD, PhD, Chin-Cheng Liu, MS, Ming-Jie Yang, MD

Blood (2005) 106 (11): 4311.

https://doi.org/10.1182/blood.V106.11.4311.4311

Published: 2005

Journal Articles

Pum2 Protein Supports Maintenance and Suppresses Differentiation of Multipotent Hematopoietic Progenitors by Regulating the Function and Activation of c-kit Receptor.

Jie Yang, B.Sc., Danislav S. Spassov, Ph.D., Ronald G. Nachtman, Ph.D., Roland Jurecic, Ph.D.

Blood (2004) 104 (11): 1692.

https://doi.org/10.1182/blood.V104.11.1692.1692

Published: 2004

NARROW

Trial in Progress: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 2 Study of AK117/Placebo in Combination with Azacitidine in Patients with Newly Diagnosed Higher-Risk Myelodysplastic Syndromes (AK117-205)

Short-Term Efficacy and Safety of Blinatumomab in Early Postinduction Intensification Therapy for Pediatric B-Cell Acute Lymphoblastic Leukemia

Clinical Study on Part Factors Affecting the Effect of Platelet Transfusion during Hematopoietic Stem Cell Transplantation

Iron Catalyzed Hydrogen Sulfide and Its Prevalence during Oxidative Events in Sickle Cell Disease

Novel Fusion Genes Involving Hnrnpc and Rarg in Acute Myeloid Leukemia Mimicking Acute Promyelocytic Leukemia

Negative Minimal Residual Disease Associated with Extended Response to Moxetumomab Pasudotox in Patients with Relapsed/Refractory Hairy Cell Leukemia: Long-Term Follow-up of Bone Marrow Immunohistochemistry Analyses from a Phase 1 Study

Co-Loaded Reversal Agent and Chemotherapeutic Nanoerythrosomes to Overcome Cancer Multidrug Resistance

Phase 1 study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemia

Biomarker Predictive Ibrutinib Response Using Profiled ABC-DLBCL Patient Derived Xenografts

Higher bone marrow LGALS3 expression is an independent unfavorable prognostic factor for overall survival in patients with acute myeloid leukemia

Characterization of the Two Populations of NK-Like CD56 + T Cells and KIR + T Cells in Human

Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia

Longitudinal Analysis of Body Mass and Composition in Survivors of Pediatric Hematological Malignancies After Allogeneic Hematopoietic Stem Cell Transplantation

High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia

Parainfluenza Virus Infections In Children with Cancer

Longitudinal Analysis of Antibody Response to Immunization in Pediatric Survivors After Allogeneic Hematopoietic Stem Cell Transplantation.

By Maintaining Cells in an Inactive CD34 − State RNA-Binding Protein Pum2 Promotes Proliferation and Inhibits Differentiation of Multipotent Hematopoietic Cells.

The Role of Truncated c-kit Receptor (tr-kit) in Maintenance and Differentiation of Hematopoietic Stem Cells and Multipotent Hematopoietic Progenitors.

Expression of Cadherins in Bone Marrow Stromal Cells Affects Capacity Supporting Expansion of CD34+ Cord Blood Cells.

Pum2 Protein Supports Maintenance and Suppresses Differentiation of Multipotent Hematopoietic Progenitors by Regulating the Function and Activation of c-kit Receptor.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only